Home › Funds › Tetragon Partners GP Ltd › IMVT

Tetragon Partners GP Ltd position in IMVT

IMMUNOVANT INC · Health Care

Tetragon Partners GP Ltd reported holding 255,934 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 1.61% of its reported portfolio and ranking #15 among its reported holdings. Tetragon Partners GP Ltd has disclosed IMVT holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)255.93K sh
Reported value held$9.86M
Portfolio Weight1.61%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's IMVT position evolved

Tetragon Partners GP Ltd first disclosed a stake in IMVT in Q1 2025 at 131,167 shares (US$2.2M). The position peaked in Q2 2026 at 255,934 shares, worth US$9.9M. Across 6 filings, Tetragon Partners GP Ltd increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 255,934 shares valued at US$9.9M — an increase of 37,427 shares quarter over quarter.. Notable position changes include a 27% increase in Q3 2025 (shares rose 58% over the following quarter), a 31% increase in Q1 2026 (shares rose 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 131.17K $2.24M New
Q2 2025 147.82K $2.37M Add
Q3 2025 188.38K $3.04M Add
Q4 2025 166.19K $4.22M Reduce
Q1 2026 218.51K $5.43M Add
Q2 2026 255.93K $9.86M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 40 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has Tetragon Partners GP Ltd held IMVT?

Tetragon Partners GP Ltd has disclosed IMVT holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Tetragon Partners GP Ltd's current position in IMVT?

As of Q2 2026, Tetragon Partners GP Ltd holds 255.93K shares of IMVT (IMMUNOVANT INC), valued at $9.86M, representing 1.61% of its reported portfolio and ranking #15.

Has Tetragon Partners GP Ltd been buying or selling IMVT?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd increased its position in IMVT. The position peaked in Q2 2026 at 255.93K shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.